Curocell recorded a single insider transaction over the past ninety days. Director Gim Su Gyeong sold 1,462 shares valued at approximately 34.7 million KRW on September 3, 2026. This divestment represents the sole activity reported during this period, occurring while the stock price remains near its fifty-two-week low despite a recent 9.6% quarterly gain.